Bacil Pharma Ltd — Updates, 14-08-2025: Company Update

Here are the summaries based on the provided document:

**Bacil Pharma Limited**

Bacil Pharma Limited has submitted the newspaper clippings of its unaudited financial results for the quarter ended June 30, 2025, to the stock exchange. This update signifies that the company's latest financial performance has been published, making key figures accessible to investors. It's a routine compliance disclosure ensuring shareholders and the public can review the company’s operational and financial standing for the recent quarter. Investors can find the full details in the published reports.

**Anuroop Packaging Limited**

Anuroop Packaging Limited has disclosed its unaudited financial results for the quarter ended June 30, 2025. On a consolidated basis, the company reported revenue from operations of Rs 3.20 Cr and a net profit after tax of Rs 0.72 Cr. Consolidated earnings per share stood at Rs 0.68. Standalone figures showed revenue of Rs 0.86 Cr and net profit of Rs 0.07 Cr. These results, approved by the Board, are available for detailed review on the company's website and the stock exchange.

**Centennial Surgical Suture Limited**

Centennial Surgical Suture Limited has announced its unaudited financial results for the quarter ended June 30, 2025. The company reported total revenue from operations of Rs 12.94 Cr. However, it posted a net loss after tax of Rs 0.04 Cr for the period. The earnings per share (EPS) for the quarter stood at (Rs 0.11). These results were reviewed by the Audit Committee and approved by the Board, offering investors insight into the company's latest financial performance.